Veru Inc share price logo

Veru Inc

NASDAQ: VERU

Small Cap

$2.27

+0.05

(+2.25%)

as on

Veru Inc Stock Performance

as on May 8, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.22
    $2.34
    downward going graph

    2.20%

    Downside

    3.08%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.06
    $7.40
    downward going graph

    9.25%

    Downside

    225.99%

    Upside

    downward going graph

Veru Inc share price movements today

Previous Close
$2.22
Open
$2.23
Volume
234.6K
Day's Low - High
$2.22 - $2.34
52 Week Low - High
$2.06 - $7.40

Veru Inc Historical Returns

1 Month Return
-10.48 %
3 Month Return
-5.13 %
1 Year Return
-55.72 %
3 Year Return
-83.43 %
5 Year Return
-97.16 %

Veru Inc Stock Fundamentals & Key Indicators

Check Veru Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$35.5M

EPS (TTM)

-1.185

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

3.5994

EBITDA

-29.9M

Revenue (TTM)

16.9M

Profit Margin

0.00%

Return On Equity TTM

-60.25%

Veru Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veru Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Veru Inc image
Veru Inc
BUY$35.5M-97.16%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.5B130.77%76.3212.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.5BNA70.895.37%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$108.5B98.9%25.3835.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$75.6B45.15%17.629.65%

Stock Returns calculator for Veru Inc Stock including INR - Dollar returns

The Veru Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Veru Inc investment value today

Current value as on today

₹50,400

Returns

-₹49,600

(-49.6%)

Returns from Veru Inc Stock

-₹54,691 (-54.69%)

Dollar Impact

₹5,091 (+5.09%)

Analyst Recommendation on Veru Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Veru Inc. Average target price of $25

Veru Inc Share Price Target

Get share price movements and forecasts by analysts on Veru Inc.

What analysts predicted

90.92%UPSIDE

Target Price

$25

Current Price

$2.27

Analyzed by

9 Analysts

Target

$25.00

Veru Inc target price $25, a slight upside of 90.92% compared to current price of $2.27. According to 9 analysts rating.

Indian Investors' Interest in Veru Inc Stock

Search interest for Veru Inc Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:3% versus previous 30 day period

Veru Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
3
-
4
3
6
-
-
-
0
-
Gross Profit
1
1
0
1
2
0
0
0
0
0
Operating Income
-11
-8
-9
-10
-8
-10
-8
-7
1
-5
EBITDA
-10
-
-9
-10
-7
-10
-9
-8
12
-5
Interest Expense
0
0
0
0
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-7
-9
-10
-8
-1
-7
-7
1
-5
Income Tax Expense
0
-
0
0
0
-7
-
-
-
-
Net Income
-23
-8
-10
-10
-8
-8
-7
-7
1
-5
Net Profit Margin
-615.43%
0.00%
-242.45%
-277.42%
-128.15%
0.00%
0.00%
0.00%
588.31%
0.00%

Veru Inc Annual Profit & Loss

All numbers in Millions USD

Sep 2016
Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
22
13
15
31
42
61
39
16
16
-
Gross Profit
13
7
8
21
30
47
30
7
5
0
Operating Income
3
-8
-20
-6
-14
12
-83
-93
-36
-24
EBITDA
4
-8
-20
-5
-14
9
-83
-89
-36
-35
Interest Expense
3
2
2
4
4
4
4
2
0
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
2
-8
-23
-12
-20
4
-83
-92
-37
-15
Income Tax Expense
2
-1
0
0
-1
-3
0
0
0
-
Net Income
0
-6
-23
-12
-18
7
-83
-93
-37
-22
Net Profit Margin
1.56%
-48.42%
-150.89%
-37.79%
-44.55%
12.07%
-212.88%
-571.60%
-223.86%
0.00%

Veru Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-8
-10
-10
-8
-8
-7
-7
1
-5
Operating Cash Flow
-6
-5
-5
-4
-11
-7
-5
-5
-6
Investing Cash Flow
-
0
0
0
17
1
0
6
-
Financing Cash Flow
36
0
0
-
-4
-
-
23
23
Change in Cash
30
-5
-5
-4
1
-6
-5
0
17

Veru Inc Annual Cash Flow

All numbers in Millions USD

Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
-6
-23
-12
-18
7
-83
-93
-37
-22
Operating Cash Flow
0
-11
-5
-1
-15
-47
-88
-21
-30
Investing Cash Flow
0
0
0
0
14
4
6
0
25
Financing Cash Flow
12
12
8
9
109
1
11
36
-4
Change in Cash
0
0
2
7
108
-42
-70
15
-9

Global Institutional Holdings in Veru Inc

Funds
Holdings
Adage Capital Partners Gp LLC
0.68%
Alyeska Investment Group, L.P.
6.23%
Summit Financial, LLC
1.02%
GSA Capital Partners LLP
1.22%
Sheets Smith Investment Management
1%
See all

Insights on Veru Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 23.4% return, outperforming this stock by 107.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 32.8% return, outperforming this stock by 90.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, VERU stock has moved down by -12.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.45M → -5.33M (in $), with an average decrease of 466.9% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 6.65M → 247.06K (in $), with an average decrease of 96.3% per quarter

About Veru Inc

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
OrganisationVeru Inc
Headquarters2916 North Miami Avenue, Miami, FL, United States, 33127
IndustryBiotechnology
CEODr. Mitchell S. Steiner F.A.C.S., M.D.
E-voting on sharesClick here to vote

Key Management of Veru Inc

Name

Title

Dr. Gary Bird Ph.D.

Executive Vice President of Quality & Regulatory Affairs

Dr. Mitchell S. Steiner F.A.C.S., M.D.

Chairman, President & CEO

Ms. Michele Greco CPA

CFO & Chief Administrative Officer

Mr. Samuel Fisch

Executive Director of Investor Relations & Corporate Communications

Mr. Philip R. Greenberg J.D.

Executive VP, General Counsel & Secretary

Mr. Martin Tayler

Executive Vice President of FC2 Global Operations

Dr. Harry D. Fisch F.A.C.S., M.D.

Vice Chairman & Chief Corporate Officer

Dr. K. Gary Barnette Ph.D.

Chief Scientific Officer

Mr. Kevin J. Gilbert CPA, J.D.

Executive Vice President of Corporate Development

Dr. Domingo Rodriguez M.D.

Executive Vice President of Global Clinical Operations

FAQs

What is Veru Inc share price today?

Veru Inc share price today is $2.27 as on at the close of the market. Veru Inc share today touched a day high of $2.34 and a low of $2.22.

What is the 52 week high and 52 week low for Veru Inc share?

Veru Inc share touched a 52 week high of $7.4 on and a 52 week low of $2.06 on . Veru Inc stock price today i.e. is closed at $2.27,which is 69.32% down from its 52 week high and 10.19% up from its 52 week low.

What is Veru Inc's market capitalisation today?

Veru Inc market capitalisation is $0.00T as on .

How to invest in Veru Inc Stock (VERU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Veru Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veru Inc Shares that will get you 0.6608 shares as per Veru Inc share price of $2.27 per share as on May 8, 2026 at 1:29 am IST.

What is the minimum amount required to buy Veru Inc Stock (VERU) from India?

Indian investors can start investing in Veru Inc (VERU) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Veru Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Veru Inc share’s latest price of $2.27 as on May 8, 2026 at 1:29 am IST, you will get 4.4053 shares of Veru Inc. Learn more about fractional shares .

What are the returns that Veru Inc has given to Indian investors in the last 5 years?

Veru Inc stock has given -97.16% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?